Switching delivery formats: A lifecycle management strategy for sterile injectables


Switching delivery formats can be an effective strategy to enhance they lifecycle of your drug. This whitepaper provides insight into the benefits and challenges of transferring a therapeutic compound from one aseptic injectable format to another, focusing specifically on the following:

  • The material and process information and data needed to inform decision-making
  • The technical and analytical requirements for ensuring product integrity
  • The regulatory and timeline considerations for commercializing the product